Lundbeck
HLUN-B.CO
#2508
Rank
โ‚น496.88 B
Marketcap
โ‚น519.19
Share price
-0.93%
Change (1 day)
23.67%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น50.40 Billion

According to Lundbeck 's latest financial reports the company's total debt is โ‚น50.40 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น51.17 B-23.02%
2022-12-31โ‚น66.48 B10.24%
2021-12-31โ‚น60.30 B-36.77%
2020-12-31โ‚น95.38 B-6.86%
2019-12-31โ‚น102.40 B
2018-12-31N/A-100%
2017-12-31โ‚น0.58 B-96.78%
2016-12-31โ‚น18.24 B-50.31%
2015-12-31โ‚น36.71 B6.1%
2014-12-31โ‚น34.60 B40.06%
2013-12-31โ‚น24.70 B33.3%
2012-12-31โ‚น18.53 B4.75%
2011-12-31โ‚น17.69 B14.64%
2010-12-31โ‚น15.43 B-50.31%
2009-12-31โ‚น31.06 B80.74%
2008-12-31โ‚น17.18 B20.06%
2007-12-31โ‚น14.31 B27.2%
2006-12-31โ‚น11.25 B311.39%
2005-12-31โ‚น2.73 B-15.44%
2004-12-31โ‚น3.23 B